Provided by Tiger Trade Technology Pte. Ltd.

Irhythm Technologies Inc.

113.00
-1.6700-1.46%
Post-market: 113.000.00000.00%16:10 EDT
Volume:649.46K
Turnover:73.50M
Market Cap:3.64B
PE:-81.18
High:116.53
Open:115.00
Low:112.31
Close:114.67
52wk High:212.00
52wk Low:92.52
Shares:32.22M
Float Shares:31.75M
Volume Ratio:1.19
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3920
EPS(LYR):-1.3920
ROE:-36.57%
ROA:-2.36%
PB:23.84
PE(LYR):-81.18

Loading ...

GUIDANCE: (IRTC) iRhythm Technologies Expects 2026 Revenue Range $870M to $880M, vs. FactSet Est of $863.6M

MT Newswires Live
·
Jan 12

iRhythm Technologies Inc FY2026 REV View $862.7 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Jan 12

iRhythm Technologies Inc: Anticipate FY25 REV to Exceed High End of Previously Stated Guidance Range of $740 Mln Provided in October 2025

THOMSON REUTERS
·
Jan 12

iRhythm Technologies Inc: for Full Year 2026, Expect Revenue of About $870 Mln to $880 Mln

THOMSON REUTERS
·
Jan 12

iRhythm Technologies Projects 2026 Revenue of Up to $880 Million

Reuters
·
Jan 12

iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire
·
Jan 12

iRhythm price target raised to $211 from $202 at Goldman Sachs

TIPRANKS
·
Jan 09

iRhythm Technologies Raised to Outperform From In-Line by Evercore ISI Group

Dow Jones
·
Jan 06

Does iRhythm Technologies (IRTC) Asia-Pacific Data Shift Its Competitive Edge in Cardiac Monitoring?

Simply Wall St.
·
Dec 23, 2025

iRhythm Technologies Is Maintained at Buy by Truist Securities

Dow Jones
·
Dec 19, 2025

Truist Securities Adjusts Price Target on iRhythm Technologies to $215 From $230, Maintains Buy Rating

MT Newswires Live
·
Dec 18, 2025

Does iRhythm Technologies (IRTC) Face a Governance Test That Could Reshape Its Innovation-Led Story?

Simply Wall St.
·
Dec 08, 2025

Chief Communications and Product Officer Chad Patterson Sells Common Shares of IRhythm Technologies Inc

Reuters
·
Dec 04, 2025

iRhythm Technologies (IRTC) Valuation After New Global Zio ECG Data From Major Cardiac Conference

Simply Wall St.
·
Dec 03, 2025

iRhythm Technologies Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Dec 03, 2025

Zio ECG Study Shows Cross-Population Efficacy and Might Change The Case For Investing In iRhythm Technologies (IRTC)

Simply Wall St.
·
Nov 28, 2025

A Closer Look at iRhythm Technologies’s (IRTC) Valuation After New Global Clinical Data Release

Simply Wall St.
·
Nov 26, 2025

iRhythm Technologies Unveils New Data Showing Consistent Zio LTCM Performance in Asian Patients

Reuters
·
Nov 21, 2025

Confident Outlook for Irhythm Technologies Amid Proposed Medicare Policy Changes

TIPRANKS
·
Nov 18, 2025

iRhythm falls -8.5%

TIPRANKS
·
Nov 17, 2025